Unknown

Dataset Information

0

TMPRSS2, a novel host-directed drug target against SARS-CoV-2.

ABSTRACT:

SUBMITTER: Keller C 

PROVIDER: S-EPMC9308027 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

TMPRSS2, a novel host-directed drug target against SARS-CoV-2.

Keller Christian C   Böttcher-Friebertshäuser Eva E   Lohoff Michael M  

Signal transduction and targeted therapy 20220723 1

Similar Datasets

Unknown Host-directed therapies against early-lineage SARS-CoV-2 retain efficacy against B.1.1.7 variant.
| S-EPMC7836107 | biostudies-literature
Other Characterization of ACTN4 as a novel antiviral target against SARS-CoV-2
2024-08-14 | GSE274550 | GEO
Unknown Extracellular Vimentin as a Target Against SARS-CoV-2 Host Cell Invasion.
| S-EPMC9252327 | biostudies-literature
Unknown Extracellular vimentin as a target against SARS-CoV-2 host cell invasion.
| S-EPMC7805437 | biostudies-literature
Unknown Host-directed editing of the SARS-CoV-2 genome.
| S-EPMC7643664 | biostudies-literature
Unknown Structural analysis of experimental drugs binding to the SARS-CoV-2 target TMPRSS2.
| S-EPMC7417922 | biostudies-literature
Unknown Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite.
| S-EPMC7953435 | biostudies-literature
Unknown Characterization of ACTN4 as a novel antiviral target against SARS-CoV-2.
| S-EPMC11408661 | biostudies-literature
Unknown Synergistic block of SARS-CoV-2 infection by combined drug inhibition of the host entry factors PIKfyve kinase and TMPRSS2 protease.
| S-EPMC8183009 | biostudies-literature
Unknown Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease.
| S-EPMC7212545 | biostudies-literature